Aperture Sectors › Healthcare & Life Sciences › Pharma commercial & medical affairs
Pharma commercial & medical affairs funding
Pharma commercial & medical affairs
A sub-sector of Healthcare & Life Sciences. Each company counts once, in its main sub-sector.
13 rounds, $296M raised by 11 companies, Jan 2, 2023 to Nov 14, 2026, 1% of Healthcare & Life Sciences capital. Top three companies: AcuityMD 42%, Sorcero 14%, Doceree 12%.
| Company | HQ | Capital raised | Rounds | Exit |
|---|---|---|---|---|
| AcuityMD | United States | $125M | 2 | — |
| Sorcero | United States | $42M | 1 | — |
| Doceree | United States | $35M | 1 | — |
| Odaia | Canada | $25M | 1 | — |
| Solstice | United States | $24M | 2 | — |
| Prudentia Sciences | United States | $20M | 1 | — |
| Reliant AI | Canada | $11M | 1 | — |
| PraxisPro | United States | $6M | 1 | — |
| Argon AI | United States | $5.5M | 1 | — |
| PBR Life Sciences | Nigeria | $1M | 1 | — |
| BranchLab | United States | $0 | 1 | — |
| Company | Amount | Stage | Announced |
|---|---|---|---|
| AcuityMD | $80M | Series C | Apr 21, 2026 |
| AcuityMD | $45M | Series B | Jun 4, 2024 |
| Sorcero | $42M | Series B | Nov 21, 2025 |
| Doceree | $35M | Series B | Sep 27, 2023 |
| Odaia | $25M | Series B | May 1, 2023 |
| Solstice | $21M | Series A | May 28, 2026 |
| Prudentia Sciences | $20M | Series A | Jan 7, 2026 |
| Reliant AI | $11M | Seed | Aug 20, 2024 |
| PraxisPro | $6M | Seed | Jan 21, 2026 |
| Argon AI | $5.5M | Seed | Jul 2, 2025 |